tiprankstipranks
Trending News
More News >
Pascal Biosciences Inc (TSE:NEVI)
:NEVI
Canadian Market

Pascal Biosciences Inc (NEVI) Income Statement

Compare
5 Followers

Pascal Biosciences Inc Income Statement

Last quarter (Q3 2025), Pascal Biosciences Inc's total revenue was C$478.81K, an increase of 0.89% from the same quarter last year. In Q3, Pascal Biosciences Inc's net income was C$-33.70K. See Pascal Biosciences Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 1.55MC$ 671.54KC$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 1.08MC$ 392.94KC$ -8.29KC$ -16.32KC$ -12.48K
Operating Expenses
C$ 1.30MC$ 1.26MC$ 548.59KC$ 1.06MC$ 1.26M
Depreciation and Amortization
C$ 251.42KC$ 106.94KC$ 8.29KC$ 16.32KC$ 12.48K
EBITDA
C$ -48.07KC$ -271.56KC$ -468.09KC$ -1.07MC$ -1.22M
Operating Income
C$ -220.15KC$ -868.13KC$ -556.88KC$ -1.08MC$ -1.27M
Other Income/Expenses
C$ -142.33KC$ 468.36KC$ 25.35KC$ -7.87KC$ -11.23K
Pretax Income
C$ -362.48KC$ -399.77KC$ -480.28KC$ -1.09MC$ -1.24M
Net Income
C$ -362.48KC$ -399.77KC$ -480.28KC$ -1.09MC$ -1.24M
Per Share Metrics
Basic EPS
C$ -0.01C$ -0.02C$ -0.04C$ -0.09C$ -0.11
Diluted EPS
C$ -0.01C$ -0.02C$ -0.04C$ -0.09C$ -0.11
Weighted Average Shares Outstanding
38.33M 23.53M 13.11M 12.70M 11.08M
Weighted Average Shares Outstanding (Diluted)
38.33M 23.53M 13.11M 12.70M 11.08M
Currency in CAD

Pascal Biosciences Inc Earnings and Revenue History